| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.6M | — | -6.9% |
| Cost of Revenue | $4.2M | — | +0.2% |
| R&D Expense | $2.4M | — | -9.9% |
| SG&A Expense | $2.1M | — | -33.1% |
| Operating Income | -$1.4M | — | +27.8% |
| Pre-tax Income | -$1.5M | — | +18.6% |
| Income Tax | $199K | — | +84.3% |
| Net Income | -$1.7M | — | +13.0% |
| EPS (Basic) | -$0.04 | — | +20.0% |
| EPS (Diluted) | -$0.04 | — | +20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.0M | -9.3% | -10.0% |
| Accounts Receivable | $6.8M | +2.3% | -10.0% |
| Current Assets | $18.1M | -4.7% | -8.9% |
| Total Assets | $38.5M | -2.9% | -5.1% |
| Current Liabilities | $8.2M | +1.5% | +2.8% |
| Total Liabilities | $9.7M | +1.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$514K | — | +80.4% |
| Investing Cash Flow | -$411K | — | -42.2% |
| Financing Cash Flow | $2K | — | -98.8% |
| +4.7% |
| Stockholders' Equity | $28.9M | -4.1% | -8.0% |